Searchable abstracts of presentations at key conferences in endocrinology

ea0096p2 | Section | UKINETS2023

The Global leadership into malnutrition criteria reveals a high percentage of malnutrition which influences overall survival in patients with gastroenteropancreatic neuroendocrine tumours using somatostatin analogues

Clement Dr. Dominique , Monique van Leerdam Prof , Tesselaar Dr. Margot , Cananea Ms. Elmie , Martin Ms. Wendy , Martin Weickert Prof , Sarker Dr. Debashis , John Ramage Prof , Srirajaskanthan Dr. Rajaventhan

Introduction: Patients with neuroendocrine tumours located in the gastroenteropancreatic tract (GEP-NETs) and treatment with somatostatin analogues (SSA’s) are at risk of malnutrition which has been reported previously, based on weight loss or body mass index (BMI) only. Since 2019 The Global leadership into malnutrition (GLIM) criteria exist to diagnose malnutrition, including weight loss, BMI and sarcopenia. These GLIM criteria have not been assessed in...

ea0096p3 | Section | UKINETS2023

High prevalence of deficiencies in fat-soluble vitamins, minerals and trace elements but no relation with malnutrition in patients with gastroenteropancreatic neuroendocrine tumours using somatostatin analogue’s

Dominique Clement Dr , Monique van Leerdam Prof , Tesselaar Dr. Margot , Cananea Ms. Elmie , Martin Ms. Wendy , Martin Weickert Prof , Brown Dr. Sarah , John Ramage Prof , Srirajaskanthan Dr. Rajaventhan

Introduction: Since 2019 the Global Leadership Into Malnutrition (GLIM) criteria exist for diagnosing malnutrition. Patients with gastoenteropancreatic (GEP) neuroendocrine tumours (NETs) using somatostatin analogue’s (SSA’s) are at risk of malnutrition. Deficiencies in fat-soluble vitamins, minerals and trace elements are not part of the GLIM criteria but frequently reported in patients with GEP-NETs using SSA’s. The relationship between malnut...